One of the most expensive words in small cap investing is cheap. It sounds like a reason to buy. It feels like a reason to buy. A stock trades at a five year low, the price to earnings multiple looks absurd next to its history, the dividend yield jumps off the screen, and something in the investor brain lights up and says bargain. That instinct has made a lot of money over the years. It has also destroyed a lot of it.
Because here is the uncomfortable truth that anyone who has spent a few cycles in Australian small and mid caps learns the hard way: cheap is not a strategy. A low price tells you what the market thinks of a company today. It tells you almost nothing about what happens next. And what happens next is the only thing that actually pays you.
The trap hiding inside a bargain
The appeal of cheapness is that it feels like a margin of safety. If a stock has already fallen seventy per cent, surely most of the damage is done. Surely the downside is limited. Surely someone will eventually notice how undervalued it is and the price will correct.
Sometimes that is exactly what happens. More often, in my experience, the thing that is cheap gets cheaper. A stock at a five year low can very comfortably go on to make a seven year low, and then a ten year low, all while the value investor who bought it congratulates himself on his patience and quietly refuses to admit the thesis was never really a thesis at all. It was just a low number.
Seth Klarman of the Baupost Group put this well in a recent conversation, and it is worth repeating because it comes from one of the most careful value investors alive. His firm has learned, sometimes painfully, that cheap on its own is not enough. When they look at an investment, the question is not simply how large the discount is to what the business might be worth. The question is what the expected return is from here, and just as importantly, what is going to drive it. If you cannot make a clear argument for why a stock works over the next year or two, then the fact that it is trading at a multi year low is not comforting. It is a warning.
That distinction is central here. A discount is not a catalyst. Value without a reason to close the gap is just a value trap wearing a nicer suit.
What actually turns cheap into a good investment
So if a low price is not the thesis, what is? In small and mid caps, the difference between a bargain and a trap almost always comes down to a handful of practical questions.
The first is the catalyst. What specifically is going to make this business worth more in the next year or two? A new contract ramping up. A loss making division being sold or closed. A balance sheet being repaired. A founder returning. An earnings margin normalising after a heavy investment phase. Cost out finally showing up in the numbers. A takeover approach. Something has to change the trajectory, because a share price does not re-rate out of sympathy. It re-rates when the facts move.
The second is the balance sheet, and I will never apologise for banging on about this. A cheap company with too much debt is not a bargain, it is an option that can expire worthless. Net debt, covenant headroom, interest cover, debt maturity dates and cash conversion decide whether a struggling business has the time to turn around, or whether it runs out of runway before the story can play out. The cheapest stocks on the ASX are very often cheap precisely because the balance sheet is doing the market a favour by scaring people away.
The third is cash. Reported earnings are an opinion, cash is a fact. A company that keeps telling a good story while its cash conversion quietly deteriorates is a company where the thesis is decaying in real time, no matter how attractive the headline multiple looks. Strong, consistent free cash flow is what lets a cheap business fund its own recovery instead of going back to shareholders with the begging bowl at exactly the wrong moment.
The fourth is management and ownership. In small caps this matters enormously. A capable, aligned management team with real skin in the game will find a way to create value from a difficult position. Insider buying at depressed prices is one of the more honest signals in this part of the market. A board that is asleep, or a management team with no meaningful shareholding, will happily preside over a slow decline while collecting their fees.
Get those four things right, catalyst, balance sheet, cash and alignment, and a cheap stock can become a genuinely good investment. Get them wrong and the discount is not your friend. It is bait.
Why this bites harder in Australian small caps
This lesson applies everywhere, but it is especially sharp in the part of the market where we spend our time.
Australian small and mid caps are less liquid, less researched and more emotional than the large end of the market. That cuts both ways. It creates the mispricings we live for, the good result that gets sold, the quality business the market has simply forgotten to look at. But it also means that when something is cheap for a bad reason, there is often no natural buyer to catch it, and the price can drift down for years on thin volume while nobody is paying attention.
Illiquidity also plays a cruel trick on patience. In a large cap, if your thesis is wrong you can usually get out at a fair price. In a small cap value trap, the exit can be as painful as the entry, because the same lack of buyers that let the stock fall so far also makes it hard to sell without pushing the price down further. Patience is a virtue in this market, but patience applied to a broken thesis is just a slow way to lose money.
The discipline, then, is to be ruthless about the difference between a business that is cheap and temporarily out of favour, and a business that is cheap and permanently impaired. The first is an opportunity. The second is a structural decline dressed up as a bargain, and no multiple is low enough to make a melting ice cube a good long term hold.
The honest counterpoint
I want to be fair to the other side, because good investing lives in the tension.
The risk of demanding a clear catalyst for everything is that you can talk yourself out of wonderful long term compounders simply because you cannot see the exact trigger yet. Some of the best investments of the last few decades looked cheap and dull for a long time before the market woke up, and an investor obsessed with near term catalysts would have missed them. Warren Buffett built a fortune partly on the willingness to buy quality and wait, sometimes for years, without a neat catalyst on the calendar.
There is also the fact that catalysts themselves are hard to time. A takeover you expect may not come. A turnaround you can see may take twice as long as management promised. Requiring a catalyst does not remove uncertainty, it just changes its shape.
So the point is not that catalysts are magic, or that a stock must have a scheduled event in the next six months to be worth owning. The point is more disciplined than that. If there is no catalyst, then the business quality had better be exceptional and the balance sheet had better be bulletproof, because you are relying on time and compounding rather than a specific change to do the work. What you cannot do is buy something ordinary, at a low price, with no reason for it to improve, and call that a value strategy. That is not investing. That is hoping.
What long term investors should take from this
For long term investors, the practical lesson is simple to say and hard to live by. When you find yourself attracted to a stock, notice whether the attraction is the price or the business. If the only thing you can say in its favour is that it has fallen a long way, that is not a reason to buy, it is a reason to do more work.
Ask what has to go right. Ask what the business is genuinely worth if things simply stabilise, not if everything goes perfectly. Ask whether the balance sheet buys enough time for the story to play out. Ask whether the people running it own enough of it to care. And be honest about whether there is any real reason, beyond the low price, for the gap to close.
Do that consistently and you will still get some wrong, because everyone does. But you will stop making the most common and most avoidable mistake in small cap investing, which is confusing a low price with a good decision.
TAMIM Takeaway
Cheap is a description, not a strategy. A low share price tells you what the market thinks today. It does not tell you what happens next, and what happens next is where the returns live. The stocks that make money are not simply the cheapest ones, they are the ones where a genuine catalyst, a sound balance sheet, real cash generation and aligned management combine to close the gap between price and value.
For long term investors, the discipline is to separate the temporarily unloved from the permanently impaired. One is opportunity, the other is a trap that gets cheaper the longer you hold it. The lesson is not to fear cheap stocks, it is to demand a reason beyond the price before you back them. In small caps especially, that single habit is often the line between patient value investing and expensive wishful thinking.
There is a comforting illusion that takes hold whenever a great company finally comes to market and the orders come flooding in. When a business is wanted badly enough, we quietly assume the money to buy it will always be there. Demand feels infinite. Capital starts to feel like water, endlessly available, ready to flow wherever the best ideas happen to be. It is one of the most natural assumptions in investing, and it is also one of the most dangerous.
Because money is not infinite. Conviction might be, enthusiasm certainly is, but the actual pool of investable capital at any given moment is a real number. It has a size. And when too many wonderful companies reach into that same pool at the same time, something has to give. Usually it is the price.
That is the quiet risk sitting underneath the current market, and it is not the risk most people are worried about. The debate everyone is having is whether artificial intelligence is a bubble, whether the winners are overvalued, whether the story holds. Those are fair questions. But there is a second, less glamorous question hiding behind them, and it may matter more over the next year: what happens when almost everyone who matters needs to raise money, or wants to sell stock, all at once?
Why this matters now
Consider what just happened. In June, SpaceX listed on the Nasdaq in the largest initial public offering on record, raising roughly USD 75 billion at a price of USD 135 a share and a valuation near USD 1.77 trillion. The stock jumped almost twenty per cent on its first day and the company briefly carried a market value above USD 2 trillion. Demand was extraordinary. Retail investors alone put in orders worth more than USD 100 billion, and the deal was reportedly oversubscribed several times over.
On the surface, that looks like a triumph of demand. Read it again and it is also a preview of supply. One company just pulled USD 75 billion of cash out of the market in a single week. And SpaceX is not the last of them. Anthropic and OpenAI, each valued privately at close to USD 1 trillion, have reportedly filed confidentially to go public, and those deals could land this year. Earlier in 2026, the chipmaker Cerebras came to market and its shares popped sharply on debut. The queue is forming, and it is a long one.
Now add the parts most investors do not see on the ticker. Every one of those blockbuster listings comes with a lock-up period. When those lock-ups expire, employees who are wealthy on paper will want to be wealthy in the bank, and they will sell. Some large university endowments are reported to hold ten to fifteen per cent of their entire portfolio in a single private name. When that name lists, they will trim. None of these people are panicking. They are simply doing the sensible thing, turning a paper fortune into real money. But the collective effect is an enormous wave of stock that has to find a buyer.
The core thesis
Here is the argument in one line: the next stress in markets may not be a story problem, it may be a supply problem.
The point is one that Seth Klarman of the Baupost Group made recently, and it is worth restating in plain terms. The cost of capital is set by the supply of money and the demand for it. We accept this instinctively in the bond market. When governments and companies all try to borrow at once, yields rise, because there is only so much lending capacity to go around. The same logic applies to equities, we just forget it, because in a bull market it feels like the buyers will always turn up.
But look at who needs money right now. The AI labs need capital, tens of billions of it, to keep training ever larger models. The hyperscalers, the Googles and Metas of the world, are spending record sums on data centres. The utilities need capital to build the power generation and grid capacity those data centres consume, because compute without electricity is just very expensive furniture. The chip companies need capital to build new fabrication plants, some of them in the United States. And now the newly listed giants need investors to absorb waves of stock as lock-ups roll off.
Everyone is reaching into the same pool at the same time. That is not a comment on whether any one of these businesses is good. Many of them are superb. It is a comment on arithmetic. When supply of securities is this heavy and the need to raise or monetise is this urgent, prices can soften for reasons that have nothing to do with fundamentals. The tide can go out even while the companies themselves are doing fine.
Where this gets interesting for investors
If that were the whole story, it would just be a warning. But there is a second-order effect that is far more useful, and it is where the opportunity may sit.
When capital becomes scarce and attention becomes narrow, markets get lazy about sorting. The instinct becomes brutally simple: own the AI winners, dump anything that smells like an AI loser, and do not think too hard about the difference. In that kind of environment, perfectly good businesses get thrown out with the bathwater. A high quality, cash generative, sensibly priced company can be sold off simply because it has been filed under the wrong heading, or because an investor needs to free up cash to chase the exciting new listing.
That is the pattern long term investors should be watching. Not the stocks everyone is fighting to buy, but the quality names quietly being discarded to fund the buying. The market is effectively running a fire sale in one aisle to pay for a bidding war in another. History suggests the fire sale aisle is usually where the better long term value ends up being.
None of this requires a heroic macro call. It does not require predicting the top, or timing the moment the supply wave crests. It simply requires remembering that when money is being drained from the system to feed a small number of hungry giants, the discipline of buying quality at a fair price becomes more valuable, not less.
The risks and the honest counterpoint
Now for the other side, because a thesis without a counterpoint is just a sales pitch.
The most important risk here is that this dynamic is easy to describe and very hard to time. Capital has been abundant for the better part of two decades. Markets have absorbed enormous waves of new supply before and simply kept climbing. Global savings are vast, foreign money keeps arriving, companies keep buying back their own shares, and the pool of capital has repeatedly proven deeper than the pessimists expected. You can be completely correct about the mechanism and still be early by two years, which in practice can feel a lot like being wrong.
There is also the possibility that the supply gets met by genuine new demand. If the AI build-out really does lift productivity and earnings the way the optimists hope, then the appetite for equities could expand to match the flood of paper. Scarcity of capital is a risk, not a certainty.
And it is worth being honest about the flip side of caution. Klarman himself has admitted that he held too much cash for too long during the era of suppressed interest rates, and that the optionality he was preserving simply did not pay off for long stretches. Waiting has a cost. Sitting in cash to dodge a supply wave that never fully arrives is its own kind of mistake. The lesson is not to hoard and hide. It is to stay disciplined about what you pay and what you own.
There is a live macro backdrop too. Kevin Warsh took over as chair of the US Federal Reserve in May, with inflation still running above target and the market at one point even pricing the chance of a rate rise rather than a cut. A higher for longer rate environment is precisely the condition under which the supply and demand for money starts to bite. That does not make a squeeze inevitable. It does make the arithmetic worth respecting.
What sensible long term investors should actually do
For long term investors, the practical response to all of this is not dramatic, which is rather the point.
The first thing is to stay bottom up. The overall market weather matters, and it pays to keep half an eye on it, but portfolios are built one holding at a time. Knowing what you own, why you own it, and what it is genuinely worth is what keeps you anchored when the headlines get loud.
The second is to think in terms of absolute return rather than keeping up with the index. When a market becomes this concentrated in a handful of enormous names, the index stops being a neutral benchmark and starts being a bet on those specific companies. Chasing it means chasing them. A sensible investor is trying to compound wealth ahead of inflation over years, not trying to match a scoreboard that a few mega caps happen to be dominating this quarter.
The third is to treat cash and quality as tools, not comfort blankets. A little cash creates the ability to act when others are forced to sell. Quality businesses with strong balance sheets are the ones most likely to survive a squeeze and take advantage of it. The opportunity, if the supply wave does soften prices, will go to the investors who kept some capacity and kept their nerve.
This is not a call to make big directional bets on the market. It is a reminder that when everyone is admiring the demand, the smart money is quietly counting the supply.
TAMIM Takeaway
The market is transfixed by a single question: who are the AI winners? Underneath that question sits a quieter and possibly more important one: where will all the money come from? A record breaking wave of listings, lock-up expiries, endowment selling and staff monetisation is arriving at the same moment that AI labs, hyperscalers, utilities and chipmakers all need enormous amounts of fresh capital. When that many winners reach into the same pool at once, the price of capital can rise and share prices can soften, even for genuinely good companies.
For long term investors, the useful mindset is not fear, it is patience with a purpose. Do not try to time the wave. Stay bottom up, focus on quality, balance sheets and valuation, keep some capacity to act, and watch the aisle where solid businesses are being discarded to fund the excitement elsewhere. That is usually where the market’s short-termism creates the long-term opportunity.
This week’s reading list explores how innovation, capital, and structural change continue to reshape the investment landscape. From the ongoing AI-driven market rally and the growing importance of semiconductor infrastructure to evolving approaches in private equity, investors are increasingly focused on identifying long-term opportunities amid rapid technological advancement. At the same time, developments in housing markets, sustainability, and monetary policy highlight the broader economic forces influencing both capital allocation and consumer behaviour. The contrast between slowing property momentum in some markets and emerging opportunities in areas such as home decarbonisation underscores the importance of looking beyond short-term cycles. Meanwhile, shifting interest rate dynamics in major economies such as Japan serve as a reminder that the global financial environment continues to evolve in meaningful ways. Across these themes, adaptability, innovation, and disciplined decision-making remain critical for investors navigating an increasingly interconnected world. This week’s selection offers insights into the trends shaping markets today and the opportunities that may define the years ahead.
There is a familiar rhythm to how markets misread central banks. The headline says “rates unchanged”. The cameras pack up. The next news cycle moves on. Three days later, the underlying repricing finally shows up in portfolios, and by then most retail investors are scrambling to understand what just happened.
Yesterday afternoon in Washington, the Federal Reserve held rates at 3.50 to 3.75 per cent. Exactly as expected. Markets had priced 97 per cent odds of a hold. That part was a non-event.
The interesting things happened in the small print. The post meeting statement was gutted of its easing bias, rewritten by new chair Kevin Warsh into what he described, with what we suspect was deliberate dryness, as “a bit shorter, a bit simpler”. The dot plot, which is the chart showing where each Fed official thinks rates are going, swung sharply hawkish. The median expectation for the cash rate at the end of 2026 jumped from 3.4 per cent in March to 3.8 per cent now, suggesting one rate hike rather than the previously implied one cut. Nine of the 18 voting members are now penciling in at least one hike this year. And the new chair, in his first press conference, refused to submit his own dot at all.
The market response was immediate. The S&P 500 closed down 1.06 per cent. The Nasdaq fell 1.34 per cent. Two year Treasury yields jumped 16 basis points to 4.21 per cent, their highest level in over a year. The US dollar gained roughly 1 per cent in its best session in almost a year. Gold fell more than 2 per cent.
For Australian investors waking up Thursday morning to read these numbers, the question is what happens next. The honest answer is that something more interesting than usual is going on, and most local commentary has not quite caught up with it.
The two central banks have just diverged
Three days ago in Sydney, the Reserve Bank of Australia held its cash rate at 4.35 per cent and signalled what most economists are now reading as a likely peak. CBA’s economics team is calling rates on hold for the rest of 2026. NAB has shifted to expecting the next move to be down, with timing uncertain. The Australian rate cycle, by domestic consensus, has plateaued.
The Federal Reserve has just told the market the opposite. The next move in the United States is more likely to be a hike than a cut. The energy shock from the Iran conflict has pushed US inflation to 4.2 per cent, the highest in three years. The US labour market is firmer than expected. The Fed is no longer in the business of preparing markets for cuts. It is preparing them for the possibility of more tightening.
This is a divergence that matters. When the world’s two most relevant central banks for an Australian portfolio start moving in opposite directions, three things happen.
The first is that the Australian dollar tends to weaken. A higher US cash rate relative to Australia means capital flows toward US assets in search of yield. The AUD has already softened against a rising USD overnight. That has implications for everything from imported inflation to the earnings of every ASX listed business with US dollar revenues or US dollar costs. Resources companies that sell into global markets benefit at the margin. Importers and businesses with US dollar denominated costs feel it the other way.
The second is that imported inflation pressure rises. A weaker AUD means more expensive imported goods, which feeds into the local CPI with a lag of three to six months. This is precisely the dynamic the RBA does not want to be facing if it has just decided the local cycle has peaked. It complicates the calculus for the Reserve Bank in a way that the futures market is only beginning to price.
The third is that long duration assets globally have just had their valuation framework reset. The discount rate applied to all future cash flows just moved higher. That hits growth stocks, tech, infrastructure trusts, listed property, and any asset where the value is weighted heavily toward earnings five or ten years out. The Nasdaq’s 1.34 per cent fall is the first indication of what that looks like in real time.
For Australian investors holding the ASX 200, most of which is resources, financials and defensives, the direct impact is more muted than for an investor holding the Nasdaq. But the secondary effects matter. Listed property, infrastructure trusts, quality growth names and the local technology sector are all exposed to the global discount rate, regardless of where the RBA goes.
Why Warsh refused to give a dot
This is the part of yesterday’s meeting that has not been properly digested yet, and it is the part that matters most for the next year.
Kevin Warsh declined to submit his own forecast for the dot plot. He stated explicitly that he does not believe in providing forward guidance. His policy statement was, in his own words, “curt”. His press conference was shorter than Powell’s. When asked detailed questions about the Fed’s reasoning, he frequently declined to elaborate. He told reporters: “I’ve got nothing more to say than the statement itself.”
This is a deliberate communication revolution. Warsh has long argued that the Fed should reduce its reliance on forward guidance and let markets do more of the work of pricing future policy themselves. He is now putting that philosophy into practice from his first meeting onward.
There are two ways to read this. The first reading is that Warsh is freeing the Fed from the trap of having to forecast its own behaviour, which has caused the central bank no end of grief over the past several years. By making the Fed less predictable, he is forcing markets to focus on actual data rather than on what officials might say. There is a school of central banking thought that views this as a genuine improvement.
The second reading is more uncomfortable. If markets can no longer rely on forward guidance, they have to price more uncertainty into every asset. Higher uncertainty means higher risk premiums. Higher risk premiums mean lower valuations, particularly for the most rate sensitive assets. The AI and technology sectors, where multiples have been propped up by the assumption of falling rates and accommodative central banks, are the most exposed. So are listed infrastructure trusts and long duration bonds.
In practice, the effect is the same regardless of which reading you prefer. The forward guidance era of the last 15 years is ending. Investors will need to make their own assessments about where rates are going, with less help from the Fed. The implications for portfolio construction are not trivial.
What this means for Australian portfolios
The temptation, on a piece of news like this, is to overreact in one direction or another. Sell everything growth oriented. Buy resources and defensives. Hide in cash. Run to gold. These responses are usually wrong, because the actual portfolio implications are more nuanced than the headlines suggest.
A few practical observations.
The Australian dollar weakness is genuinely useful for parts of the ASX. Resources companies with USD revenue (BHP, Rio Tinto, Woodside, the major gold producers) get a translation benefit. Healthcare names with US earnings (CSL is the obvious one, though the stock has had a brutal year for other reasons) get a similar benefit. Listed companies with substantial offshore earnings, including some industrials and global financials, see the same effect. This does not change the underlying business quality of any of these names, but it does affect reported earnings.
The flip side is also true. Australian businesses with USD denominated costs (anything that imports equipment, technology, hardware or pharmaceuticals) face higher input costs. Discount retailers exposed to global supply chains, technology businesses paying USD for cloud services, and certain industrial businesses face margin pressure. Some of this can be hedged, but the structural exposure is real.
For listed infrastructure and listed property, the message is more cautious than it would have been a week ago. The bond yield rise overnight is exactly the kind of move that compresses multiples on long duration assets. Goodman Group, Transurban, the major REITs, the listed utilities. All of these had benefited from the RBA peaking. They now face a headwind from the global discount rate moving the other way. Quality remains attractive but valuations are no longer drifting in their favour the way they were two weeks ago.
For technology and growth names, both globally and locally, the environment has just become more demanding. The AI capex story, which is being financed partly by cheap capital and partly by faith in falling discount rates, has just had one of those legs kicked. This does not break the long term thesis, but it does increase the demands placed on actual earnings delivery. Companies that have been priced for perfection will be tested.
For defensives and dividend yielders, the relative attractiveness has improved. When long duration assets re-rate down, the high yielding income compounders look better in comparison. The major banks, despite the obvious cyclical risks, are now yielding meaningfully above what is available offshore on a risk adjusted basis. Consumer staples, telecommunications, regulated utilities and other classic defensive sectors quietly benefit from the rotation, even though most commentators are not framing it that way.
What to do, and what to avoid
The single most important thing for Australian investors right now is to avoid overreacting to a single piece of news, however significant.
The Fed’s hawkish shift overnight is real and it is meaningful. But it is also just one data point in a longer story. The next few months will tell us whether the inflation pressure resolves quickly with an oil de-escalation, or whether it gets embedded in expectations and forces a hike. The data will tell us whether the US labour market continues to firm, or whether it softens. The next Fed meeting in late July will tell us whether yesterday’s hawkish tilt was the start of a tightening cycle or simply a re-centring of policy at the current level.
Long term portfolios should not be rebuilt around a single press conference. They should be stress tested against the regime that is now becoming clearer, which is one of higher for longer rates, persistent inflation, geopolitical tension, and central banks that are less willing to telegraph their next moves. The portfolio that handles that regime well is not exotic. It is a portfolio of quality businesses with pricing power, sensible balance sheets, durable cash flow and disciplined capital allocation. It has a sensible allocation to real assets and inflation linked income. It has enough defensive yield to compound through the noise. It does not depend on the discount rate doing the heavy lifting.
The investors who handle these moments best are not the ones who make the most dramatic moves. They are the ones who recognise the regime shift early, adjust gradually at the edges, and stay focused on quality. The market will do plenty of repricing without anyone needing to throw their portfolio in the air.
What could go wrong
A few risks are worth flagging.
The first is that the hawkish shift overnight could be overdone. Warsh’s reluctance to provide his own forecast suggests he may actually be less hawkish than the committee. The dot plot may turn out to be a high water mark rather than a starting point. If the oil price de-escalates, headline inflation falls quickly, and the labour market softens through autumn, the Fed could be back to neutral or even dovish by year end. Investors who position too aggressively for sustained hawkishness could give back gains quickly.
The second is the inverse. The Fed could actually deliver one or two hikes if inflation stays sticky. The 80 per cent probability now priced in swaps markets for at least one more US hike by year end is not trivial. If those hikes arrive, the AUD weakens further, imported inflation rises, the RBA’s job gets harder, and the local rate cycle peak may turn out to be temporary rather than structural.
The third is broader market volatility. New Fed chairs typically take time to establish their communication style, and Warsh has explicitly told markets to expect less hand holding. That means more volatility around economic data releases, more risk that markets misread Fed intentions, and more potential for sharp moves in either direction. Portfolios that depend on stable conditions or low volatility need to be stress tested for the new regime.
And finally, the geopolitical backdrop remains the most important wildcard. The Middle East situation has been the swing factor in inflation, oil and risk appetite for months. A genuine resolution would change the macro story overnight in a benign direction. A further escalation would do the opposite. Most portfolios are not positioned for either extreme, and that is probably the right place to be.
TAMIM Takeaway
The interesting things in markets rarely happen on the days when everyone is watching. They happen in the small print of statements, in the abstention of a single dot, in the quiet divergence between two central banks that no one has framed clearly yet.
The Federal Reserve and the Reserve Bank of Australia have just started moving in opposite directions for the first time in this cycle. The Fed is now signalling more tightening. The RBA is signalling the peak. That divergence has implications for the Australian dollar, for imported inflation, for the discount rate applied to every long duration Australian asset, and for the relative attractiveness of different parts of the ASX.
Most Australian investors will not have processed any of this yet. The local commentary will catch up over the next week. The market itself will reprice over the next month. By the time the headlines make the divergence obvious, the move will be well underway.
For long term investors, the practical response is the same one that works at every cycle turn. Recognise the regime shift early. Do not overreact to a single piece of news. Tilt portfolios thoughtfully toward quality, real assets, and defensive income. Accept that the path is uncertain and that no single forecast, including this one, will be exactly right.
The Fed has just changed the rules of how it talks to markets. Investors who keep waiting for clear forward guidance will be the ones most surprised by what comes next. The rest of us can keep doing what good long term investors have always done. Own quality. Pay sensible prices. Compound through the noise. And remember that the regime is always shifting at the margin, even when it looks settled.
There is a strange quality to the current market conversation. Roughly every second equity story that crosses the desk this year is some variation on artificial intelligence, GPU demand, hyperscaler capex, or the next great compute cycle. Some of this is justified. The capital being spent on AI infrastructure is real, the demand profile of large models is real, and the productivity story will probably turn out to be real too, even if the timing and the recipients of the benefits look rather different in 2030 than the consensus today expects.
But this preoccupation with one theme, however genuine, has a habit of starving sensible investors of attention for other things. A portfolio fully exposed to a single thematic, no matter how good the thematic, is not a portfolio. It is a concentrated bet dressed up in diversification language. And when the discount rate moves the wrong way, or the capex cycle disappoints, or the geopolitical backdrop shifts in a way that nobody priced for, the concentration shows.
What follows is a brief look at three businesses we hold or have recently added to portfolios. None of them are AI. None of them are technology in any meaningful sense. All three are doing something useful, generate cash, are run by management teams that appear awake, and trade at multiples that do not require heroic forecasts to support. In other words, they are the kind of boring businesses that quietly compound when the more glamorous parts of the market are busy reminding investors that gravity still applies.
SATS Limited (SGX: S58)
SATS sits at the unfashionable intersection of aviation ground handling, air cargo, inflight catering, and a growing range of institutional food and hospitality services. The business operates across Singapore, the wider Asia Pacific, the Americas, Europe, the Middle East and Africa, with the headline asset being its dominant position at Changi, the world’s most consistently well run major aviation hub.
The FY26 results, released on 25 May, were materially better than the consensus expected. Revenue reached a record S$6.35 billion, up 9 per cent on the prior year. Net profit rose 17 per cent to S$285.2 million. Gross debt to EBITDA improved from 3.7 times to 3.3 times. And the final dividend was lifted to 5.0 cents per share, taking the full year payout to 7.0 cents, an increase of roughly 40 per cent on the prior year.
It is worth dwelling on that dividend move for a moment. In Singapore, a 40 per cent lift in distributions is not a casual decision. It is a signal from a board that has reviewed the balance sheet, the operating outlook, and the capital plan, and concluded that the business is generating more than enough cash to fund growth and return more to shareholders. Singapore companies do not lift dividends to flatter the share price. They lift them because the numbers comfortably support it. Watch the dividend in any Temasek influenced business and you will usually learn more than from the management commentary.
The Middle East situation has been a complicating factor. Flight cancellations, rerouted cargo, higher fuel costs, and disrupted supply chains all weighed on the fourth quarter. The good news is that SATS’s global network has actually benefited from some of the disruption. Cargo flows rerouted away from disrupted Middle Eastern hubs have been picked up by SATS’s facilities in Singapore, North America and Europe. Changi, in particular, has become structurally more important as a transit point for both passenger and freight traffic around the affected region. A world in which Hormuz remains contested is a world in which Singapore matters more, not less.
The growth pipeline is also more diversified than the inflight catering legacy might suggest. The Aviapartner cargo acquisition is contributing meaningfully. The expansion into non aviation food services for institutions, hospitality and the defence sector is gathering pace, including the recently demonstrated logistics capability for Exercise Wallaby. The pivot from a Singapore centric airline caterer to a global aviation services and food solutions group is now well advanced, and the financial results are starting to reflect it.
On valuation, SATS trades at around 21 times current year earnings and 18 times next year, with the multiple compressing as the deleveraging benefits flow through. EV/EBITDA at around 7.5 times is undemanding for a business with this kind of structural position. The dividend yield is modest at 1.8 per cent but the rate of growth is what matters. We see a quality compounder with a global infrastructure backbone, structural tailwinds from supply chain reshoring and aviation recovery, and a balance sheet that has just been visibly strengthened by management with capital discipline. The kind of business it is hard to build, easy to underestimate, and difficult to replicate.
Encompass Health Corporation (NYSE: EHC)
Encompass Health operates the largest network of inpatient rehabilitation hospitals in the United States and Puerto Rico, providing specialised post acute care for patients recovering from major injury or illness. Stroke. Spinal cord injury. Hip replacement. Cardiac surgery. The kinds of clinical pathways where intensive rehabilitation makes a measurable difference to long term outcomes, and where the alternative to specialist inpatient care is poorer recovery, longer hospital stays, and higher overall costs to the health system.
The investment case is built on three structural drivers that are unlikely to reverse. American demographics, with the over 65 population continuing to grow at roughly double the rate of the total population. The continued shift toward post acute specialisation, as health systems realise that acute care hospitals are an expensive place to convalesce. And the genuine scarcity of high quality inpatient rehabilitation capacity in many US markets, which keeps occupancy rates high and gives Encompass meaningful pricing leverage with both Medicare and private insurance.
The recent share price weakness has been driven by two specific concerns. The first is reported pressure from large health insurance companies pushing for more aggressive pricing rebates on post acute services. The second is the broader uncertainty around Medicare policy under the current administration, with Robert Kennedy Jr’s department signalling potential changes to several elements of the program. Both of these concerns are real. Neither, in our view, breaks the long term thesis.
The reason is that Encompass operates in a structurally undersupplied part of the US healthcare system. The company is currently expanding capacity, with seven new hospitals planned. Occupancy rates are high. Margins are healthy. EBITDA margins reached 23.3 per cent in FY25 and are expected to remain above 21 per cent through the cycle. EBIT margins are running close to 18 per cent. And critically, the company has been raising guidance through 2026, not lowering it. EBITDA and EPS forecasts have moved up, even as the share price has moved down. That is the kind of dislocation that creates opportunities for investors willing to look past the immediate news flow.
Valuation has compressed accordingly. Encompass trades at roughly 17 times current year earnings and around 16 times next year, with a price to sales ratio of just 1.6 times. For a healthcare services business with double digit revenue growth, expanding margins, raising guidance, and a clear path to capacity expansion, this is not a demanding multiple. The 12 month analyst price target average sits at $140.50 against a current share price around $103. The dividend yield is modest at 0.74 per cent but the company has a long record of capital return through buybacks and selective dividend increases.
We do not pretend that the Medicare risk is zero. Policy changes are genuinely difficult to forecast, and the rebate pressure from insurers is a real margin headwind. But the business is structurally well positioned, the management team has navigated multiple Medicare cycles, the balance sheet is reasonable, and the demographic backdrop is undeniable. At a time when the technology sector demands ever more aggressive growth forecasts to justify multiples that already assume miracles, owning a healthcare business with raising guidance at 17 times earnings looks rather sensible by comparison. We particularly like the contrast with the so called Magnificent Seven, where we now have virtually no exposure on valuation grounds. Encompass offers a different profile entirely: structural growth, dependable margins, a real asset base, and a multiple that allows for ordinary disappointments without permanent capital loss.
Aena S.M.E., S.A. (BME: AENA)
Aena is the world’s largest airport operator by passenger volume. It operates 46 airports and two heliports across Spain, holds majority stakes in 17 airports in Brazil, owns Luton Airport in the United Kingdom, and has additional interests in Mexico and Colombia. The Spanish government, through ENAIRE, retains a 51 per cent stake. The remaining shareholder base is dominated by global institutional investors including BlackRock, Veritas Asset Management, and Goldman Sachs.
The simple version of the investment case is that Aena is a near monopoly on Spanish air travel, a country that has positioned itself as the dominant European tourism destination over the past decade. Spain received over 90 million international visitors in 2024 and the numbers have continued to climb. Madrid Barajas, Barcelona El Prat, the Canary Islands airports, and the Balearics network all sit inside Aena’s portfolio. The business has the pricing power that comes with monopoly position, the long term concession structure that provides revenue visibility, and the operating leverage that comes with high fixed cost infrastructure.
The financials reflect the quality of the asset base. Revenue grew 20.4 per cent in 2023, 14.6 per cent in 2024, and 8.8 per cent in 2025, reaching €6.3 billion. EBITDA margins are now running above 58 per cent and are expected to expand further to roughly 60 per cent over the forecast period. Net income margins approach 35 per cent. The business is fundamentally a real estate operation with airline ground rents, retail concessions, and parking fees as the underlying revenue streams. Anyone who has paid for parking at Madrid or Barcelona will recognise the pricing power instinctively.
Critically, Aena is not a Middle East victim. Its passenger base is dominated by intra European travel, North American visitors to Spain, and Latin American flows through Madrid. The Strait of Hormuz situation is not material to the underlying business. If anything, the geopolitical disruption to Middle Eastern hubs has made Madrid a more important transit point for certain South American to European flows, which is helpful at the margin.
The balance sheet is also notable. Net debt to EBITDA sits at around one times, materially below the European listed airport peer group where two to three times is closer to the norm. This is the operating discipline that comes with majority Spanish government ownership and a board that values cash flow generation over financial engineering. It also gives the business meaningful capacity to fund growth, return capital, or absorb shocks without distress.
On valuation, Aena trades at roughly 16 times current year earnings and around 10 times EV/EBITDA. The dividend yield is 4.4 per cent, paid out of genuinely high quality cash flows. This is not a screaming bargain, but it is a reasonable price for a global infrastructure asset with a near monopoly position, structural tourism tailwinds, conservative leverage and double digit free cash flow yields once you adjust for maintenance capex. Compare that with what you pay for any number of US listed AI infrastructure proxies and the relative attractiveness becomes clear.
A note on Luton. Owning Luton Airport is the sort of thing that prompts wry comment from anyone who has actually been through it. The terminal is small. The infrastructure is older than ideal. The reputation is, to put it mildly, not in the same conversation as Heathrow or Madrid. But Luton sits in a structurally short London airport capacity environment, has continued to grow passenger volumes, and is an opportunity for capacity investment that the British government has been notably reluctant to grant to the larger airports. The fact that Aena bought it cheaply and is improving it incrementally is probably a better outcome than the alternative of leaving it to drift. Investors who can put aside their personal experience of arriving at gate 24 at 2 a.m. on a delayed Ryanair flight may find themselves rewarded.
A common thread
What ties these three businesses together is not sector. It is character.
Each one is a structural participant in something useful that the global economy will continue to need regardless of what happens to large language models. People will continue to travel through Singapore. Americans will continue to need post acute rehabilitation as they age. Tourists will continue to fly into Spain. None of these demand functions depend on a successful AI investment cycle, a particular discount rate, or a benign geopolitical outcome.
Each one is run by a management team that has demonstrated capital discipline. SATS is deleveraging meaningfully while growing. Encompass is funding expansion from operating cash flow rather than equity dilution. Aena maintains conservative leverage in a sector where peers routinely run two or three times the debt. In a market environment where capital discipline has become genuinely scarce, this matters more than it usually does.
And each one trades at a multiple that does not require optimism to justify. SATS at 18 times next year earnings. Encompass at 16 times. Aena at 16 times current year and 10 times EBITDA. These are not bargain basement valuations, but they are reasonable prices for genuinely good businesses, and they allow for the ordinary disappointments of business life without inflicting permanent damage on the long term return.
Risks
A few honest risks before concluding.
SATS is exposed to global passenger traffic, cargo volumes and fuel prices. A meaningful recession, a sustained Middle East escalation that disrupts global aviation more broadly, or a sharp rise in input costs would all hurt margins. The deleveraging story is sound but the business is still in transition from the WFS acquisition and execution risks remain.
Encompass faces real headwinds from Medicare policy uncertainty and insurer pricing pressure. The expanding capacity build has execution risk and capital intensity that the market may continue to underprice. A material policy change to the post acute care reimbursement model would be more damaging than current weakness suggests.
Aena is exposed to the European tourism cycle, which has been strong but is not infinite. A sustained European recession, a further deterioration in fuel costs that affects airline behaviour, or a sharp shift in Spanish regulation around tourism volumes would all affect the business. The Brazil and Luton exposures add operational complexity. And the 51 per cent ENAIRE ownership means the Spanish government retains real influence over how the business is run, which can be helpful or unhelpful depending on the political cycle.
None of these risks are deal breakers. All of them are reasonable to think about. The work for any sensible investor is to size positions appropriately, monitor the businesses through the cycle, and remember that the absence of a fashionable narrative is sometimes the most valuable feature an investment can have.
TAMIM Takeaway
Markets in 2026 have become unusually concentrated around a single thematic. Some of that concentration is justified by the genuine quality of the underlying businesses driving it. Most of it is the usual late cycle phenomenon of capital chasing the loudest story and forgetting that other parts of the economy still exist, still generate cash, still serve real needs, and still deserve a place in a balanced portfolio.
SATS, Encompass Health, and Aena are not exciting in the way the AI infrastructure story is exciting. None of them will be on a magazine cover this year. None of them will generate the kind of share price moves that make for compelling dinner party stories. What they will do, in our view, is what good long term businesses have always done. Compound earnings through cycles. Return cash to shareholders sensibly. Hold up reasonably well when the rest of the market is being repriced by macro forces that have nothing to do with the underlying business.
The investors who do best over long horizons are rarely the ones who own the most fashionable portfolio at any particular moment. They are the ones who built portfolios that work across regimes, that contain businesses they understand, that pay reasonable prices for above average quality, and that do not depend on a single thematic continuing forever. In a year when AI has dominated the conversation, owning some businesses that have nothing to do with AI is not a contrarian gesture. It is basic portfolio construction. That, plus a reasonable cash flow yield, plus management teams that respect their own balance sheets, will probably do more for long term returns than chasing the next variant of the same trade everyone else is already in.
Disclaimer: SATS Limited (SGX: S58), Encompass Health Corporation (NYSE: EHC) and Aena S.M.E., S.A. (BME: AENA) are held in TAMIM portfolios as at the date of article publication. Holdings can change substantially at any time.
